{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:27:11Z","timestamp":1789010831971,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.81803895"],"award-info":[{"award-number":["No.81803895"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"crossref","award":["ZR2021YQ57"],"award-info":[{"award-number":["ZR2021YQ57"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["No.2020M682131"],"award-info":[{"award-number":["No.2020M682131"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["No.2021T140357"],"award-info":[{"award-number":["No.2021T140357"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Intrahepatic cholangiocarcinoma (ICC) accounts for about 15% of primary liver cancer, and the incidence rate has been rising in recent years. Surgical resection is the best treatment for ICC, but the 5-year survival rate is less than 30%. ICC signature genes are crucial for the early diagnosis of ICC, so it is especially important to find its signature genes and therapeutic drug. Here, we studied that bufalin targeting CAMKK2 promotes mitochondrial dysfunction and inhibits the occurrence and metastasis of intrahepatic cholangiocarcinoma through Wnt\/\u03b2-catenin signal pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      IC50 of bufalin in ICC cells was determined by CCK8 and invasive and migratory abilities were verified by wound healing, cell cloning, transwell and Western blot. IF and IHC verified the expression of CAMKK2 between ICC patients and normal subjects. BLI and pull-down demonstrated the binding ability of bufalin and CAMKK2. Bioinformatics predicted whether CAMKK2 was related to the Wnt\/\u03b2-catenin pathway. SKL2001, an activator of \u03b2-catenin, verified whether bufalin acted through this pathway. In vitro and in vivo experiments verified whether overexpression of CAMKK2 affects the proliferative and migratory effects of ICC. Transmission electron microscopy verified mitochondrial integrity. Associated Ca\n                      <jats:sup>2+<\/jats:sup>\n                      levels verified the biological effects of ANXA2 on ICC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      It was found that bufalin inhibited the proliferation and migration of ICC, and CAMKK2 was highly expressed in ICC, and its high expression was positively correlated with poor prognosis.CAMKK2 is a direct target of bufalin, and is associated with the Wnt\/\u03b2-catenin signaling pathway, which was dose-dependently decreased after bufalin treatment. In vitro and in vivo experiments verified that CAMKK2 overexpression promoted ICC proliferation and migration, and bufalin reversed this effect. CAMKK2 was associated with Ca\n                      <jats:sup>2+<\/jats:sup>\n                      , and changes in Ca\n                      <jats:sup>2+<\/jats:sup>\n                      content induced changes in the protein content of ANXA2, which was dose-dependently decreasing in cytoplasmic ANXA2 and dose-dependently increasing in mitochondrial ANXA2 after bufalin treatment. In CAMKK2 overexpressing cells, ANXA2 was knocked down, and we found that reversal of CAMKK2 overexpression-induced enhancement of ICC proliferation and migration after siANXA2.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results suggest that bufalin targeting CAMKK2 promotes mitochondrial dysfunction and inhibits the proliferation and migration of intrahepatic cholangiocarcinoma through Wnt\/\u03b2-catenin signal pathway. Thus, bufalin, as a drug, may also be used for cancer therapy in ICC in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-023-04613-6","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T11:03:56Z","timestamp":1702292636000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Bufalin targeting CAMKK2 inhibits the occurrence and development of intrahepatic cholangiocarcinoma through Wnt\/\u03b2-catenin signal pathway"],"prefix":"10.1186","volume":"21","author":[{"given":"Huhu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanghao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8668-0433","authenticated-orcid":false,"given":"Lina","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,11]]},"reference":[{"key":"4613_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2022.110504","volume":"101","author":"H Shirvani","year":"2023","unstructured":"Shirvani H, Ghanavi J, Aliabadi A, Mousavinasab F, Talebi M, Majidpoor J, Najafi S, Miryounesi SM, Aghaei Zarch SM. MiR-211 plays a dual role in cancer development: from tumor suppressor to tumor enhancer. Cell Signal. 2023;101: 110504.","journal-title":"Cell Signal"},{"key":"4613_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2022.110525","volume":"101","author":"L Bahari Khasraghi","year":"2023","unstructured":"Bahari Khasraghi L, Nouri M, Vazirzadeh M, Hashemipour N, Talebi M, Aghaei Zarch F, Majidpoor J, Kalhor K, Farnia P, Najafi S, Aghaei Zarch SM. MicroRNA-206 in human cancer: mechanistic and clinical perspectives. Cell Signal. 2023;101: 110525.","journal-title":"Cell Signal"},{"key":"4613_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.125863","volume":"250","author":"M Fattahi","year":"2023","unstructured":"Fattahi M, Shahrabi S, Saadatpour F, Rezaee D, Beyglu Z, Delavari S, Amrolahi A, Ahmadi S, Bagheri-Mohammadi S, Noori E, Majidpoor J, Nouri S, Aghaei-Zarch SM, Falahi S, Najafi S, Le BN. microRNA-382 as a tumor suppressor? Roles in tumorigenesis and clinical significance. Int J Biol Macromol. 2023;250: 125863.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"4613_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12935-023-02868-z","volume":"23","author":"M Faramin Lashkarian","year":"2023","unstructured":"Faramin Lashkarian M, Hashemipour N, Niaraki N, Soghala S, Moradi A, Sarhangi S, Hatami M, Aghaei-Zarch F, Khosravifar M, Mohammadzadeh A, Najafi S, Majidpoor J, Farnia P, Aghaei-Zarch SM. MicroRNA-122 in human cancers: from mechanistic to clinical perspectives. Cancer Cell Int. 2023;23(1):29.","journal-title":"Cancer Cell Int"},{"issue":"2","key":"4613_CR5","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3322\/caac.21759","volume":"73","author":"D Moris","year":"2023","unstructured":"Moris D, Palta M, Kim C, Allen PJ, Morse MA, Lidsky ME. Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and\u00a0future\u00a0therapeutic landscape for clinicians. CA Cancer J Clin. 2023;73(2):198\u2013222.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4613_CR6","doi-asserted-by":"publisher","first-page":"2156255","DOI":"10.1080\/19490976.2022.2156255","volume":"15","author":"X Chai","year":"2023","unstructured":"Chai X, Wang J, Li H, Gao C, Li S, Wei C, Huang J, Tian Y, Yuan J, Lu J, Gao D, Zheng Y, Huang C, Zhou J, Shi G, Ke A, Liu F, Fan J, Cai J. Intratumor microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma. Gut Microbes. 2023;15(1):2156255.","journal-title":"Gut Microbes"},{"issue":"1","key":"4613_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12967-022-03342-6","volume":"20","author":"H Yang","year":"2022","unstructured":"Yang H, Yan M, Li W, Xu L. SIRP\u03b1 and PD1 expression on tumor-associated macrophage predict prognosis of intrahepatic cholangiocarcinoma. J Transl Med. 2022;20(1):140.","journal-title":"J Transl Med"},{"issue":"10","key":"4613_CR8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s11604-019-00860-0","volume":"37","author":"M Hamaoka","year":"2019","unstructured":"Hamaoka M, Kozaka K, Matsui O, Komori T, Matsubara T, Yoneda N, Yoshida K, Inoue D, Kitao A, Koda W, Gabata T, Kobayashi S. Early detection of intrahepatic cholangiocarcinoma. Jpn J Radiol. 2019;37(10):669\u201384.","journal-title":"Jpn J Radiol"},{"issue":"3","key":"4613_CR9","doi-asserted-by":"publisher","first-page":"107327481772924","DOI":"10.1177\/1073274817729245","volume":"24","author":"NN Massarweh","year":"2017","unstructured":"Massarweh NN, El-Serag HB. Epidemiology of hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer control. 2017;24(3):1073274817729245.","journal-title":"Cancer control"},{"key":"4613_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12879-016-1643-7","volume":"16","author":"C Wang","year":"2016","unstructured":"Wang C, Jing H, Sha D, Wang W, Chen J, Cui Y, Han J. HBV-associated intrahepatic cholangiocarcinoma with high serum alpha-fetoprotein: a case report with review of literature. BMC Infect Dis. 2016;16:295.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"4613_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12967-020-02437-2","volume":"18","author":"L Wang","year":"2020","unstructured":"Wang L, Zhu H, Zhao Y, Pan Q, Mao A, Zhu W, Zhang N, Lin Z, Zhou J, Wang Y, Zhang Y, Wang M, Feng Y, He X, Xu W, Wang L. Comprehensive molecular profiling of intrahepatic cholangiocarcinoma in the Chinese population and therapeutic experience. J Transl Med. 2020;18(1):273.","journal-title":"J Transl Med"},{"issue":"3","key":"4613_CR12","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/sj.onc.1210648","volume":"27","author":"F Meng","year":"2008","unstructured":"Meng F, Wehbe-Janek H, Henson R, Smith H, Patel T. Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene. 2008;27(3):378\u201386.","journal-title":"Oncogene"},{"issue":"6","key":"4613_CR13","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1001\/jamaoncol.2019.0270","volume":"5","author":"RT Shroff","year":"2019","unstructured":"Shroff RT, Javle MM, Xiao L, Kaseb AO, Varadhachary GR, Wolff RA, Raghav KPS, Iwasaki M, Masci P, Ramanathan RK, Ahn DH, Bekaii-Saab TS, Borad MJ. Gemcitabine, cisplatin, and nab-paclitaxel for the treatment of advanced biliary tract cancers: a phase 2 clinical trial. JAMA Oncol. 2019;5(6):824\u201330.","journal-title":"JAMA Oncol"},{"issue":"2","key":"4613_CR14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s12079-020-00592-1","volume":"15","author":"MA Najar","year":"2021","unstructured":"Najar MA, Rex DAB, Modi PK, Agarwal N, Dagamajalu S, Karthikkeyan G, Vijayakumar M, Chatterjee A, Sankar U, Prasad TSK. A complete map of the calcium\/calmodulin-dependent protein kinase kinase 2 (CAMKK2) signaling pathway. J Cell Commun Signal. 2021;15(2):283\u201390.","journal-title":"J Cell Commun Signal"},{"issue":"8","key":"4613_CR15","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1080\/01635581.2021.2020305","volume":"74","author":"X Li","year":"2022","unstructured":"Li X, Miao S, Li F, Ye F, Yue G, Lu R, Shen H, Ye Y. Cellular calcium signals in cancer chemoprevention and chemotherapy by phytochemicals. Nutr Cancer. 2022;74(8):2671\u201385.","journal-title":"Nutr Cancer"},{"issue":"6","key":"4613_CR16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41585-022-00588-z","volume":"19","author":"TL Pulliam","year":"2022","unstructured":"Pulliam TL, Goli P, Awad D, Lin C, Wilkenfeld SR, Frigo DE. Regulation and role of CAMKK2 in prostate cancer. Nat Rev Urol. 2022;19(6):367\u201380.","journal-title":"Nat Rev Urol"},{"issue":"2","key":"4613_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/hep.27832","volume":"62","author":"F Lin","year":"2015","unstructured":"Lin F, Marcelo KL, Rajapakshe K, Coarfa C, Dean A, Wilganowski N, Robinson H, Sevick E, Bissig KD, Goldie LC, Means AR, York B. The camKK2\/camKIV relay is an essential regulator of hepatic cancer. Hepatology (Baltimore, Md). 2015;62(2):505\u201320.","journal-title":"Hepatology (Baltimore, Md)."},{"issue":"34","key":"4613_CR18","doi-asserted-by":"publisher","first-page":"14188","DOI":"10.1074\/jbc.M117.778464","volume":"292","author":"AM Gocher","year":"2017","unstructured":"Gocher AM, Azabdaftari G, Euscher LM, Dai S, Karacosta LG, Franke TF, Edelman AM. Akt activation by Ca(2+)\/calmodulin-dependent protein kinase kinase 2 (CaMKK2) in ovarian cancer cells. J Biol Chem. 2017;292(34):14188\u2013204.","journal-title":"J Biol Chem"},{"issue":"5","key":"4613_CR19","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1021\/acs.jproteome.1c00008","volume":"20","author":"MA Najar","year":"2021","unstructured":"Najar MA, Modi PK, Ramesh P, Sidransky D, Gowda H, Prasad TSK, Chatterjee A. Molecular profiling associated with calcium\/calmodulin-dependent protein kinase kinase 2 (CAMKK2)-mediated carcinogenesis in gastric cancer. J Proteome Res. 2021;20(5):2687\u2013703.","journal-title":"J Proteome Res"},{"key":"4613_CR20","doi-asserted-by":"publisher","first-page":"1141331","DOI":"10.3389\/fcell.2023.1141331","volume":"11","author":"H Zhang","year":"2023","unstructured":"Zhang H, Zhang Z, Guo T, Chen G, Liu G, Song Q, Li G, Xu F, Dong X, Yang F, Cao C, Zhong D, Li S, Li Y, Wang M, Li B, Yang L. Annexin A protein family: focusing on the occurrence, progression and treatment of cancer. Front Cell Dev Biol. 2023;11:1141331.","journal-title":"Front Cell Dev Biol"},{"issue":"Pt 2","key":"4613_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1242\/jcs.110.2.221","volume":"110","author":"M Jost","year":"1997","unstructured":"Jost M, Zeuschner D, Seemann J, Weber K, Gerke V. Identification and characterization of a novel type of annexin-membrane interaction: Ca2+ is not required for the association of annexin II with early endosomes. J Cell Sci. 1997;110(Pt 2):221\u20138.","journal-title":"J Cell Sci"},{"issue":"4","key":"4613_CR22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/ijc.34048","volume":"151","author":"Y Huang","year":"2022","unstructured":"Huang Y, Jia M, Yang X, Han H, Hou G, Bi L, Yang Y, Zhang R, Zhao X, Peng C, Ouyang X. Annexin A2: the diversity of pathological effects in tumorigenesis and immune response. Int J Cancer. 2022;151(4):497\u2013509.","journal-title":"Int J Cancer"},{"issue":"18","key":"4613_CR23","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.3748\/wjg.v26.i18.2126","volume":"26","author":"LW Qiu","year":"2020","unstructured":"Qiu LW, Liu YF, Cao XQ, Wang Y, Cui XH, Ye X, Huang SW, Xie HJ, Zhang HJ. Annexin A2 promotion of hepatocellular carcinoma tumorigenesis via the immune microenvironment. World J Gastroenterol. 2020;26(18):2126\u201337.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4613_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12929-018-0430-8","volume":"25","author":"CY Chen","year":"2018","unstructured":"Chen CY, Lin YS, Chen CH, Chen YJ. Annexin A2-mediated cancer progression and therapeutic resistance in nasopharyngeal carcinoma. J Biomed Sci. 2018;25(1):30.","journal-title":"J Biomed Sci"},{"issue":"5","key":"4613_CR25","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.3390\/molecules28052231","volume":"28","author":"AA Farooqi","year":"2023","unstructured":"Farooqi AA, Rakhmetova VS, Kapanova G, Tashenova G, Tulebayeva A, Akhenbekova A, Ibekenov O, Turgambayeva A, Xu B. Bufalin-mediated regulation of cell signaling pathways in different cancers: spotlight on JAK\/STAT, Wnt\/\u03b2-catenin, mTOR, TRAIL\/TRAIL-R, and non-coding RNAs. Molecules (Basel, Switzerland). 2023;28(5):2231.","journal-title":"Molecules (Basel, Switzerland)."},{"key":"4613_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106442","volume":"184","author":"L Soumoy","year":"2022","unstructured":"Soumoy L, Ghanem GE, Saussez S, Journe F. Bufalin for an innovative therapeutic approach against cancer. Pharmacol Res. 2022;184: 106442.","journal-title":"Pharmacol Res"},{"issue":"5","key":"4613_CR27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3892\/ol.2020.12028","volume":"20","author":"F Chen","year":"2020","unstructured":"Chen F, Zhu L, Hu J, Jiang S, Liu H, Zheng J, Wang J, Wang F, Li Z. Bufalin attenuates triple-negative breast cancer cell stemness by inhibiting the expression of SOX2\/OCT4. Oncol Lett. 2020;20(5):171.","journal-title":"Oncol Lett"},{"issue":"5","key":"4613_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004297","volume":"10","author":"Z Yu","year":"2022","unstructured":"Yu Z, Li Y, Li Y, Zhang J, Li M, Ji L, Tang Y, Zheng Y, Sheng J, Han Q, Li F, Guo J, Wang L, Sun X, Gao Y, Feng H. Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma. J Immunother Cancer. 2022;10(5): e004297.","journal-title":"J Immunother Cancer"},{"issue":"4","key":"4613_CR29","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.21037\/jtd-23-486","volume":"15","author":"Q Ju","year":"2023","unstructured":"Ju Q, Shi Q, Liu C, Fu G, Shi H. Bufalin suppresses esophageal squamous cell carcinoma progression by activating the PIAS3\/STAT3 signaling pathway. J Thorac Dis. 2023;15(4):2141\u201360.","journal-title":"J Thorac Dis"},{"issue":"9","key":"4613_CR30","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.3390\/molecules27092944","volume":"27","author":"P Tang","year":"2022","unstructured":"Tang P, Liu D, Wu Z, Cui H, Zhang R, Kuang Z. Inhibitory effects and mechanism of the natural compound diaporthein B extracted from marine-derived fungi on colon cancer cells. Molecules (Basel, Switzerland). 2022;27(9):2944.","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"1","key":"4613_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bcp.2006.03.017","volume":"72","author":"M Emmons","year":"2006","unstructured":"Emmons M, Boulware D, Sullivan DM, Hazlehurst LA. Topoisomerase II beta levels are a determinant of melphalan-induced DNA crosslinks and sensitivity to cell death. Biochem Pharmacol. 2006;72(1):11\u20138.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"4613_CR32","first-page":"1425","volume":"14","author":"G Liu","year":"2023","unstructured":"Liu G, Li X, Yang F, Qi J, Shang L, Zhang H, Li S, Xu F, Li L, Yu H, Li Y, Dong X, Song Q, Zhu F, Chen G, Cao C, Jiang L, Su J, Yang L, Xu X, Zhang Z, Zhao RC, Li B. C-Phycocyanin ameliorates the senescence of mesenchymal stem cells through ZDHHC5-mediated autophagy via PI3K\/AKT\/mTOR pathway. Aging Dis. 2023;14(4):1425\u201340.","journal-title":"Aging Dis"},{"issue":"9\u201310","key":"4613_CR33","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1007\/s10495-023-01855-z","volume":"28","author":"G Chen","year":"2023","unstructured":"Chen G, Zhang H, Sun H, Ding X, Liu G, Yang F, Feng G, Dong X, Zhu Y, Wang X, Wang Y, Li B, Yang L. Bufalin targeting BFAR inhibits the occurrence and metastasis of gastric cancer through PI3K\/AKT\/mTOR signal pathway. Apoptosis. 2023;28(9\u201310):1390\u2013405.","journal-title":"Apoptosis"},{"issue":"3","key":"4613_CR34","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s10565-021-09621-0","volume":"39","author":"S Zhang","year":"2023","unstructured":"Zhang S, Hu S, Dong W, Huang S, Jiao Z, Hu Z, Dai S, Yi Y, Gong X, Li K, Wang H, Xu D. Prenatal dexamethasone exposure induces anxiety- and depressive-like behavior of male offspring rats through intrauterine programming of the activation of NRG1-ErbB4 signaling in hippocampal PV interneurons. Cell Biol Toxicol. 2023;39(3):657\u201378.","journal-title":"Cell Biol Toxicol"},{"key":"4613_CR35","doi-asserted-by":"publisher","first-page":"1610013","DOI":"10.3389\/pore.2021.1610013","volume":"27","author":"Y Kobayashi","year":"2021","unstructured":"Kobayashi Y, Kitazono I, Akahane T, Yanazume S, Kamio M, Togami S, Nohara S, Sakamoto I, Yokoyama S, Tabata K, Kobayashi H, Tanimoto A. Molecular evaluation of endometrial dedifferentiated carcinoma, endometrioid carcinoma, carcinosarcoma, and serous carcinoma using a custom-made small cancer panel. Pathol Oncol Res. 2021;27:1610013.","journal-title":"Pathol Oncol Res"},{"issue":"49","key":"4613_CR36","doi-asserted-by":"publisher","first-page":"15084","DOI":"10.1073\/pnas.1521316112","volume":"112","author":"HN Zhang","year":"2015","unstructured":"Zhang HN, Yang L, Ling JY, Czajkowsky DM, Wang JF, Zhang XW, Zhou YM, Ge F, Yang MK, Xiong Q, Guo SJ, Le HY, Wu SF, Yan W, Liu B, Zhu H, Chen Z, Tao SC. Systematic identification of arsenic-binding proteins reveals that hexokinase-2 is inhibited by arsenic. Proc Natl Acad Sci USA. 2015;112(49):15084\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"4613_CR37","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1142\/S0192415X23500246","volume":"51","author":"CJ Huang","year":"2023","unstructured":"Huang CJ, Zhang CY, Zhao YK, Wang D, Zhuang L, Qian L, Xie L, Zhu Y, Meng ZQ. Bufalin inhibits tumorigenesis and SREBP-1-mediated lipogenesis in hepatocellular carcinoma via modulating the ATP1A1\/CA2 Axis. Am J Chin Med. 2023;51(2):461\u201385.","journal-title":"Am J Chin Med"},{"issue":"1","key":"4613_CR38","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41392-021-00701-5","volume":"6","author":"F Yu","year":"2021","unstructured":"Yu F, Yu C, Li F, Zuo Y, Wang Y, Yao L, Wu C, Wang C, Ye L. Wnt\/\u03b2-catenin signaling in cancers and targeted therapies. Signal Transduct Target Ther. 2021;6(1):307.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"4613_CR39","doi-asserted-by":"publisher","first-page":"7088","DOI":"10.1111\/jcmm.14611","volume":"23","author":"P Zhou","year":"2019","unstructured":"Zhou P, Zhang X, Guo M, Guo R, Wang L, Zhang Z, Lin Z, Dong M, Dai H, Ji X, Lu H. Ginsenoside Rb1 ameliorates CKD-associated vascular calcification by inhibiting the Wnt\/\u03b2-catenin pathway. J Cell Mol Med. 2019;23(10):7088\u201398.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"4613_CR40","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s10620-022-07609-2","volume":"68","author":"PC Adams","year":"2023","unstructured":"Adams PC. Hepatocellular carcinoma in hemochromatosis: where or when? Dig Dis Sci. 2023;68(1):12\u20133.","journal-title":"Dig Dis Sci"},{"issue":"8","key":"4613_CR41","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1161\/CIRCRESAHA.120.316857","volume":"127","author":"C Zhang","year":"2020","unstructured":"Zhang C, Zhou T, Chen Z, Yan M, Li B, Lv H, Wang C, Xiang S, Shi L, Zhu Y, Ai D. Coupling of integrin \u03b15 to annexin A2 by flow drives endothelial activation. Circ Res. 2020;127(8):1074\u201390.","journal-title":"Circ Res"},{"issue":"3","key":"4613_CR42","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cmet.2020.06.019","volume":"32","author":"K Vasan","year":"2020","unstructured":"Vasan K, Werner M, Chandel NS. Mitochondrial metabolism as a target for cancer therapy. Cell Metab. 2020;32(3):341\u201352.","journal-title":"Cell Metab"},{"issue":"12","key":"4613_CR43","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1002\/jcp.25349","volume":"231","author":"Y Yang","year":"2016","unstructured":"Yang Y, Karakhanova S, Hartwig W, D\u2019Haese JG, Philippov PP, Werner J, Bazhin AV. Mitochondria and mitochondrial ROS in cancer: novel targets for anticancer therapy. J Cell Physiol. 2016;231(12):2570\u201381.","journal-title":"J Cell Physiol"},{"key":"4613_CR44","first-page":"118763","volume":"10","author":"MG Sabbir","year":"1867","unstructured":"Sabbir MG, Taylor CG, Zahradka P. (2020) Hypomorphic CAMKK2 in EAhy926 endothelial cells causes abnormal transferrin trafficking, iron homeostasis and glucose metabolism. Biochim Biophys Acta Mol Cell Res. 1867;10:118763.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"4613_CR45","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/591241","volume":"2012","author":"YP Hsiao","year":"2012","unstructured":"Hsiao YP, Yu CS, Yu CC, Yang JS, Chiang JH, Lu CC, Huang HY, Tang NY, Yang JH, Huang AC, Chung JG. Triggering apoptotic death of human malignant melanoma a375s2 cells by bufalin: involvement of caspase cascade-dependent and independent mitochondrial signaling pathways. Evid Based Complement Alternat Med. 2012;2012: 591241.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"4613_CR46","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3892\/ijo.2012.1683","volume":"42","author":"SH Hong","year":"2013","unstructured":"Hong SH, Kim GY, Chang YC, Moon SK, Kim WJ, Choi YH. Bufalin prevents the migration and invasion of T24 bladder carcinoma cells through the inactivation of matrix metalloproteinases and modulation of tight junctions. Int J Oncol. 2013;42(1):277\u201386.","journal-title":"Int J Oncol"},{"issue":"1","key":"4613_CR47","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3892\/ijo.2015.3250","volume":"48","author":"JQ Gai","year":"2016","unstructured":"Gai JQ, Sheng X, Qin JM, Sun K, Zhao W, Ni L. The effect and mechanism of bufalin on regulating hepatocellular carcinoma cell invasion and metastasis via Wnt\/\u03b2-catenin signaling pathway. Int J Oncol. 2016;48(1):338\u201348.","journal-title":"Int J Oncol"},{"key":"4613_CR48","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.canlet.2021.06.029","volume":"520","author":"Z Jing","year":"2021","unstructured":"Jing Z, He X, Jia Z, Sa Y, Yang B, Liu P. NCAPD2 inhibits autophagy by regulating Ca(2+)\/CAMKK2\/AMPK\/mTORC1 pathway and PARP-1\/SIRT1 axis to promote colorectal cancer. Cancer Lett. 2021;520:26\u201337.","journal-title":"Cancer Lett"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04613-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04613-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04613-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T22:03:52Z","timestamp":1702332232000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04613-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,11]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4613"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04613-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,11]]},"assertion":[{"value":"10 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted in compliance with the ethical guidelines established by the institutional ethical committee of the Qingdao University (Qingdao, China, Ethical approval number: QDU-AEC-2022507). All human experiments were conducted in compliance with the ethical guidelines established by the institutional ethical committee of the Qingdao University (Qingdao, China, Ethical approval number: QDU-HEC-2022289).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing of interests"}}],"article-number":"900"}}